Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evaluate Pharma
Pharma
Orphan drug market to reach $270B by 2028: Evaluate
The high-flying drug sector is set for a slight sales growth slowdown throughout the decade, according to Evaluate's 2024 Orphan Drug Report.
Zoey Becker
Apr 24, 2024 12:01am
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Roche and Keytruda will lead company, drug sales in 2028: report
Aug 21, 2023 8:50am
AbbVie predicted to be top pharma company by sales in 2028
Jun 1, 2022 6:33am
Pharma's quarterly earnings shows lots of growth despite COVID
Aug 11, 2021 11:30am
Hey Sanofi, you need to freshen up your pipeline: report
Jan 23, 2020 11:31am
